Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P2.01 - Advanced NSCLC
- 09:00 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P2.01-021 - Efficacy of Single-Agent Chemotherapy after Exposure to Nivolumab in Advanced Non-Small Cell Lung Cancer
09:00 - 09:00 | Presenter: Yuto Yasuda | Author(s): Tomoko Funazo, T. Nomizo, T. Tsuji, Hironori Yoshida, Yuichi Sakamori, H. Nagai, H. Ozasa, T. Hirai, Y.H. Kim
- Abstract
Loading...
-
+
P2.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P2.03-055 - Comparison of Afatinib Versus Erlotinib for Advanced Non-Small-Cell Lung Cancer Patients with Resistance to EGFR-TKI
09:30 - 09:30 | Presenter: Yuichi Sakamori | Author(s): Yuto Yasuda, Tomoko Funazo, T. Nomizo, T. Tsuji, Hironori Yoshida, H. Nagai, H. Ozasa, T. Hirai, Y.H. Kim
- Abstract
Loading...
-
+
P2.07 - Immunology and Immunotherapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
-
+
P2.07-003 - Nivolumab for Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Hironori Yoshida | Author(s): Y.H. Kim, H. Ozasa, H. Nagai, Yuichi Sakamori, T. Tsuji, T. Nomizo, Tomoko Funazo, Yuto Yasuda, T. Hirai
- Abstract
Loading... -
+
P2.07-013 - Efficacy and Safety of Nivolumab in Non-Small Cell Lung Cancer with Preexisting Interstitial Lung Disease
09:30 - 09:30 | Presenter: Osamu Kanai | Author(s): Y.H. Kim, Y. Demura, M. Kanai, K. Fujita, Hironori Yoshida, M. Akai, T. Mio, T. Hirai
- Abstract
Loading... -
+
P2.07-017 - Association between Thyroid Dysfunction and Progression-Free Survival in Patients with Non-Small Cell Lung Cancer Received Nivolumab
09:30 - 09:30 | Presenter: Tomoko Funazo | Author(s): H. Ozasa, T. Nomizo, Yuto Yasuda, T. Tsuji, Hironori Yoshida, Yuichi Sakamori, H. Nagai, T. Hirai, Y.H. Kim
- Abstract
Loading... -
+
P2.07-024 - Real-World Data of Nivolumab for Previously Treated Non-Small Cell Lung Cancer Patients in Japan: A Multicenter Retrospective Cohort Study
09:30 - 09:30 | Presenter: Daichi Fujimoto | Author(s): H. Yoshioka, Yuki Kataoka, Y.H. Kim, K. Tomii, T. Ishida, M. Hirabayashi, S. Hara, M. Ishitoko, Y. Fukuda, M.H. Hwang, N. Sakai, M. Fukui, H. Nakaji, T. Hirai
- Abstract
Loading...
-
+
P2.12 - Pulmonology/Endoscopy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Pulmonology/Endoscopy
-
+
P2.12-006a - CT Findings Reduce the Risk of EBUS-TBNA
09:30 - 09:30 | Presenter: K. Kambara | Author(s): R. Hayashi, Z. Setou, T. Hirai, K. Shimokawa, K. Tokui, C. Taka, S. Okazawa, M. Inomata, S. Imanishi, T. Yamada, T. Miwa, S. Matui, K. Tobe, Y. Akemoto, N. Kitamura, T. Homma
- Abstract
Loading...